Skip to main content
. 2021 Mar 25;12:1891. doi: 10.1038/s41467-021-22132-0

Fig. 3. Histologic changes in rhesus macaques infected with MARV with and without treatment.

Fig. 3

a–d Tissues of positive control rhesus D6-Ctrl. MARV IHC positive (brown) a sinusoidal lining cells of the liver and Kupffer cells, b mononuclear cells in the splenic red and white pulp, c MARV IHC positive (red) epithelial and mononuclear cells within the ciliary body of the eye (arrows), d MARV IHC positive (brown) of mononuclear cells within the sinuses of the axillary lymph node. eh Tissues of remdesivir treated rhesus D6-GS-1 that succumbed to disease 14 dpi. e No appreciable MARV IHC immunolabeling of the liver, f No appreciable MARV IHC immunolabeling of the spleen, g MARV IHC positive (red) epithelial and mononuclear cells within the ciliary body of the eye (arrows), d MARV IHC positive (brown) of glial cells within brain. i–l Tissues of remdesivir treated rhesus D6-GS-3 that succumbed to disease 7 dpi. MARV IHC positive (brown) i sinusoidal lining cells of the liver and Kupffer cells, j mononuclear cells in the splenic red and white pulp, k MARV IHC positive (red) mononuclear cells within the ciliary body of the eye (arrow), l MARV IHC positive (brown) of mononuclear cells within the sinuses of the axillary lymph node. mp Tissues of MR186-YTE treated rhesus D6-MR-1 that succumbed to disease 9 dpi. MARV IHC positive (brown) m sinusoidal lining cells of the liver and Kupffer cells, n mononuclear cells in the splenic red and white pulp, o MARV IHC positive (red) epithelial and mononuclear cells within the ciliary body of the eye (arrows), p MARV IHC positive (brown) of mononuclear cells within the sinuses of the axillary lymph node. qt Tissues of combination remdesivir and MR186-YTE treated rhesus D6-Comb-1 that succumbed to disease 14 dpi. q No appreciable MARV IHC immunolabeling of the liver, r No appreciable MARV IHC immunolabeling of the spleen, s No appreciable MARV IHC immunolabeling (red) of the eye, t MARV IHC positive (brown) of glial cells within brain (arrow). ux Tissues of combination remdesivir and MR186-YTE treated rhesus D6-Comb-2 that survived to study end point. u No appreciable MARV IHC immunolabeling of the liver, v No appreciable MARV IHC immunolabeling of the spleen, w No appreciable MARV IHC immunolabeling (red) of the eye, x No appreciable MARV IHC immunolabeling of the brain. ybb Tissues of combination remdesivir and/ MR186-YTE treated rhesus D6-Comb-4 that succumbed to disease 7 dpi. MARV IHC positive (brown) y sinusoidal lining cells of the liver and Kupffer cells, z mononuclear cells in the splenic red and white pulp, aa MARV IHC positive (red) epithelial and mononuclear cells within the ciliary body of the eye (arrows), bb MARV IHC positive (brown) of mononuclear cells within the sinuses of the axillary lymph node. Images captured at 20x (a, e, i, m, q, u, y, d, h, l, p, t, x, & bb) 10x (b, f, j, n, r, v, z, c, g, k, o, s, w, & aa) IHC labeling for anti-MARV antigen (brown) (a, b, d, e, f, h, i, j, l, m, n, p, q, r, t, u, v, x, y, z, & bb) IHC labeling for anti-MARV antigen (red) (c, g, k, o, s, w, & aa). For each animal, displayed images are representative of histopathological lesions and immunoreactivity observed in multiple tissue slices and/or fields of view, unless otherwise indicated.